FAAH and major depressive disorder: Subject to replication, these results might encourage investigation of reversible FAAH inhibitors as potential new treatment alternatives for BPD and stimulate research investigating FAAH status in conditions often co-occurring with BPD, such as major depressive disorder and substance use disorders, for which therapeutic modulation of FAAH has been proposed and the evidence base is currently stronger.